Dow Up2.00% Nasdaq Up1.66%

Galectin Therapeutics, Inc. (GALT)

-NCM
1.08 Down 0.05(4.42%) Feb 12, 3:59PM EST
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
Net Income (15,788) (12,088) (9,675)
Operating Activities, Cash Flows Provided By or Used In
Depreciation10  12  9  
Adjustments To Net Income4,470  3,789  2,792  
Changes In Accounts Receivables -   -   -  
Changes In Liabilities(783)842  (571)
Changes In Inventories -   -   -  
Changes In Other Operating Activities(335)(39)(55)
Total Cash Flow From Operating Activities (12,426) (7,484) (7,500)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures -   -  (5)
Investments(400) -   -  
Other Cash flows from Investing Activities -   -  69  
Total Cash Flows From Investing Activities (400) -   64  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock31,465  8,609  10,403  
Net Borrowings -   -   -  
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 31,465   8,609   10,403  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents 18,639   1,125   2,967  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.